Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder. (12th June 2016)
- Record Type:
- Journal Article
- Title:
- Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder. (12th June 2016)
- Main Title:
- Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder
- Authors:
- Rajabalaya, Rajan
David, Sheba R
Chellian, Jestin
Xin Yun, Gwee
Chakravarthi, Srikumar - Abstract:
- Abstract: Context : Overactive bladder (OAB) is a common problem and anticholinergic drugs are first-line therapy, but they have side effects. Objective : Development of oxybutynin chloride (OC) proniosomal gels and analyses of its efficacy for OAB treatment. Materials and methods : Phase separation coacervation was used to prepare proniosomal gels using various non-ionic surfactants, lipids, soy lecithin and isopropyl alcohol. Gels were characterized with regard to entrapment efficiency (EE), vesicle size, surface morphology (using environmental scanning electron microscopy [E-SEM]), stability, attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, in vitro skin permeation, in vivo animal studies and histopathology. Results and discussion : EE was 87–92%, vesicle size was 0.38–5.0 μm, and morphology showed some loosened pores in proniosomes after hydration. ATR-FTIR spectroscopy showed no significant shifts in peaks corresponding to OC and excipients. Most formulations exhibited >50% permeation but the cholesterol-containing formulations P3 (Span 20:Span 60 [1:1]) and P4 [Tween 20:Tween 80 (1:1)] had the highest percent cumulative permeation. P3 and P4 also showed faster recovery of cholinergic effects on salivary glands than oral formulations. P3 and P4 had pronounced therapeutic effects in reduction of urinary frequency and demonstrated improvements in bladder morphology (highly regenerative surface of the transitional epithelium). Conclusion :Abstract: Context : Overactive bladder (OAB) is a common problem and anticholinergic drugs are first-line therapy, but they have side effects. Objective : Development of oxybutynin chloride (OC) proniosomal gels and analyses of its efficacy for OAB treatment. Materials and methods : Phase separation coacervation was used to prepare proniosomal gels using various non-ionic surfactants, lipids, soy lecithin and isopropyl alcohol. Gels were characterized with regard to entrapment efficiency (EE), vesicle size, surface morphology (using environmental scanning electron microscopy [E-SEM]), stability, attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, in vitro skin permeation, in vivo animal studies and histopathology. Results and discussion : EE was 87–92%, vesicle size was 0.38–5.0 μm, and morphology showed some loosened pores in proniosomes after hydration. ATR-FTIR spectroscopy showed no significant shifts in peaks corresponding to OC and excipients. Most formulations exhibited >50% permeation but the cholesterol-containing formulations P3 (Span 20:Span 60 [1:1]) and P4 [Tween 20:Tween 80 (1:1)] had the highest percent cumulative permeation. P3 and P4 also showed faster recovery of cholinergic effects on salivary glands than oral formulations. P3 and P4 had pronounced therapeutic effects in reduction of urinary frequency and demonstrated improvements in bladder morphology (highly regenerative surface of the transitional epithelium). Conclusion : These results suggest that OC could be incorporated into proniosomal gels for transdermal delivery in the treatment of OAB. … (more)
- Is Part Of:
- Drug delivery. Volume 23:Number 5(2016:Jul.)
- Journal:
- Drug delivery
- Issue:
- Volume 23:Number 5(2016:Jul.)
- Issue Display:
- Volume 23, Issue 5 (2016)
- Year:
- 2016
- Volume:
- 23
- Issue:
- 5
- Issue Sort Value:
- 2016-0023-0005-0000
- Page Start:
- 1578
- Page End:
- 1587
- Publication Date:
- 2016-06-12
- Subjects:
- Oxybutynin chloride -- permeation -- proniosomal gel -- salivary secretion -- transdermal delivery
Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/10717544.2015.1116027 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1009.xml